Balance Sheet INVO Bioscience, Inc.

Equities

INVO

US44984F4019

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Other stock markets 21:00:00 18/09/2024 BST			5-day change	1st Jan Change
0.6855 ^USD	+0.37%		+1.18%	-49.22%

08-14	Earnings Flash (INVO) INVO BIOSCIENCE Posts Q2 Loss $-0.62 Per Share	MT
08-14	Earnings Flash (INVO) INVO BIOSCIENCE Posts Q2 Revenue $1.8M	MT

744eb4ca08a28cbc505081c2e4.Wf7GuuaA2sQ62pjAbVcG98jaO2C8c-bMB2Vdc7TZ29U.ErOsgqrugJZdi8KPJBttnouVCxfJLKqOTCIuOPyG7acTkKuMsNasjQqcwQ

Published financial data: INVO BIOSCIENCE, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2019	2020	2021	2022	2023
Revenues	1.48M	1.04M	4.16M	822K	3.02M
Total Revenues	1.48M	1.04M	4.16M	822K	3.02M
Cost of Goods Sold, Total	140K	79.04K	126K	287K	1.93M
Gross Profit	1.34M	958K	4.03M	535K	1.09M
Selling General & Admin Expenses, Total	3.03M	6.07M	9.02M	10.57M	7.49M
R&D Expenses	-	398K	216K	544K	166K
Depreciation & Amortization - (IS)	-	9.72K	18.73K	44.6K	201K
Other Operating Expenses, Total	3.03M	6.47M	9.25M	11.16M	7.85M
Operating Income	-1.69M	-5.51M	-5.22M	-10.63M	-6.77M
Interest Expense, Total	-379K	-2.84M	-1.27M	-59.44K	-926K
Interest And Investment Income	-	4.19K	3.66K	308	-
Net Interest Expenses	-379K	-2.83M	-1.26M	-59.14K	-926K
Income (Loss) On Equity Invest.	-	-	-328K	-201K	-60.27K
Currency Exchange Gains (Loss)	-	-	-3.53K	-3.46K	-420
EBT, Excl. Unusual Items	-2.07M	-8.35M	-6.81M	-10.89M	-7.75M
Gain (Loss) On Sale Of Investments	-	-	-	-	-89.79K
Legal Settlements	-93.75K	-	-	-	-
Other Unusual Items	-	-	159K	-	-163K
EBT, Incl. Unusual Items	-2.17M	-8.35M	-6.65M	-10.89M	-8.01M
Income Tax Expense	433	36	4.76K	2.87K	27.79K
Earnings From Continuing Operations	-2.17M	-8.35M	-6.65M	-10.89M	-8.03M
Net Income to Company	-2.17M	-8.35M	-6.65M	-10.89M	-8.03M
Net Income - (IS)	-2.17M	-8.35M	-6.65M	-10.89M	-8.03M
Net Income to Common Incl Extra Items	-2.17M	-8.35M	-6.65M	-10.89M	-8.03M
Net Income to Common Excl. Extra Items	-2.17M	-8.35M	-6.65M	-10.89M	-8.03M
Per Share Items
Net EPS - Basic	-8.93	-30.41	-12.52	-17.97	-5.13
Basic EPS - Continuing Operations	-8.93	-30.41	-12.52	-17.97	-5.13
Basic Weighted Average Shares Outstanding	243K	274K	532K	606K	1.57M
Net EPS - Diluted	-8.93	-30.41	-12.6	-18	-5.13
Diluted EPS - Continuing Operations	-8.93	-30.41	-12.6	-18	-5.13
Diluted Weighted Average Shares Outstanding	243K	274K	532K	606K	1.57M
Normalized Basic EPS	-5.34	-19.01	-8.01	-11.23	-3.09
Normalized Diluted EPS	-5.34	-19.01	-8.01	-11.23	-3.09
Supplemental Items
EBITDA	-1.68M	-5.5M	-5.19M	-10.55M	-6.57M
EBITA	-1.69M	-5.51M	-5.21M	-10.62M	-6.77M
EBIT	-1.69M	-5.51M	-5.22M	-10.63M	-6.77M
EBITDAR	-1.66M	-5.48M	-	-	-
Total Revenues (As Reported)	1.48M	1.04M	4.16M	822K	3.02M
Effective Tax Rate - (Ratio)	-0.02	-0	-0.07	-0.03	-0.35
Current Domestic Taxes	-	-	4.09K	2.06K	29.74K
Total Current Taxes	-	-	4.09K	2.06K	29.74K
Deferred Domestic Taxes	433	36	670	811	-1.95K
Total Deferred Taxes	433	36	670	811	-1.95K
Normalized Net Income	-1.3M	-5.22M	-4.26M	-6.81M	-4.85M
Interest on Long-Term Debt	50.18K	2.84M	1.27M	59.44K	926K
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	-	398K	216K	544K	166K
Net Rental Expense, Total	19.83K	24.98K	-	-	-
Imputed Operating Lease Interest Expense	141K	920K	-	-	-
Imputed Operating Lease Depreciation	-121K	-895K	-	-	-
Stock-Based Comp., SG&A Exp. (Total)	181K	1.6M	2.71M	2.22M	1.39M
Stock-Based Comp., Other (Total)	46K	156K	-	120K	180K
Total Stock-Based Compensation	227K	1.76M	2.71M	2.34M	1.57M

Fiscal Period: December	2019	2020	2021	2022	2023
Assets
Cash And Equivalents	1.24M	10.1M	5.68M	90.14K	232K
Total Cash And Short Term Investments	1.24M	10.1M	5.68M	90.14K	232K
Accounts Receivable, Total	7.56K	21.7K	50.47K	77.15K	141K
Total Receivables	7.56K	21.7K	50.47K	77.15K	141K
Inventory	101K	265K	288K	264K	265K
Prepaid Expenses	196K	158K	283K	190K	622K
Total Current Assets	1.54M	10.54M	6.31M	621K	1.26M
Gross Property Plant And Equipment	252K	264K	2.62M	2.4M	6.8M
Accumulated Depreciation	-56.7K	-52.26K	-78.21K	-153K	-234K
Net Property Plant And Equipment	195K	212K	2.54M	2.24M	6.57M
Long-term Investments	-	98.08K	1.49M	1.24M	3.09M
Goodwill	-	-	-	-	5.88M
Other Intangibles, Total	57.1K	94.96K	132K	-	4.09M
Other Long-Term Assets, Total	-	240	-	-	-
Total Assets	1.8M	10.95M	10.47M	4.1M	20.89M
Liabilities
Accounts Payable, Total	359K	264K	443K	1.35M	2.33M
Accrued Expenses, Total	406K	593K	582K	946K	722K
Short-term Borrowings	-	694K	-	763K	1.51M
Current Portion of Long-Term Debt	-	-	-	-	-
Current Portion of Leases	21.36K	22.71K	222K	232K	398K
Current Income Taxes Payable	912	1.06K	-	-	-
Unearned Revenue Current, Total	714K	714K	5.9K	120K	409K
Other Current Liabilities	-	-	-	-	2.85M
Total Current Liabilities	1.5M	2.29M	1.25M	3.41M	8.22M
Long-Term Debt	355K	-	-	-	1.25M
Long-Term Leases	81.49K	58.63K	1.9M	1.67M	5.52M
Unearned Revenue Non Current	3.57M	2.86M	-	-	-
Deferred Tax Liability Non Current	433	469	1.14K	1.95K	-
Other Non Current Liabilities	-	-	-	-	5M
Total Liabilities	5.51M	5.2M	3.16M	5.08M	19.99M
Preferred Stock Convertible	-	-	-	-	6M
Total Preferred Equity	-	-	-	-	6M
Common Stock, Total	15.63K	964	1.19K	1.22K	249
Additional Paid In Capital	20.16M	37.98M	46.2M	48.8M	52.71M
Retained Earnings	-23.89M	-32.24M	-38.89M	-49.78M	-57.82M
Total Common Equity	-3.71M	5.74M	7.31M	-978K	-5.11M
Total Equity	-3.71M	5.74M	7.31M	-978K	893K
Total Liabilities And Equity	1.8M	10.95M	10.47M	4.1M	20.89M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	247K	521K	604K	699K	2.74M
ECS Total Common Shares Outstanding	244K	482K	596K	609K	2.49M
Book Value / Share	-15.2	11.92	12.26	-1.61	-2.05
Tangible Book Value	-3.77M	5.65M	7.18M	-978K	-15.08M
Tangible Book Value Per Share	-15.44	11.72	12.04	-1.61	-6.05
Total Debt	457K	775K	2.12M	2.66M	8.68M
Net Debt	-781K	-9.32M	-3.56M	2.57M	8.45M
Debt Equivalent Oper. Leases	159K	200K	-	-	-
Equity Method Investments, Total	-	98.08K	1.49M	1.24M	916K
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	44.33K	72.02K	67.6K	68.72K	53.48K
Inventories - Work In Process, Total	55.5K	29.64K	-	-	-
Inventories - Finished Goods, Total	1.55K	164K	220K	195K	211K
Machinery, Total	135K	184K	483K	493K	522K
Full Time Employees	5	10	10	15	25
Part Time Employees	-	-	2	1	5

Fiscal Period: December	2019	2020	2021	2022	2023
Net Income	-2.17M	-8.35M	-6.65M	-10.89M	-8.03M
Depreciation & Amortization - CF	20.79K	32.67K	164K	305K	201K
Amortization of Goodwill and Intangible Assets - (CF)	4.56K	1.81K	1.81K	1.81K	-
Depreciation & Amortization, Total	25.35K	34.48K	166K	306K	201K
Amortization of Deferred Charges, Total - (CF)	337K	2.49M	1.19M	52.64K	720K
(Gain) Loss on Sale of Investments - (CF)	-	-	-	-	89.79K
Asset Writedown & Restructuring Costs	-	-	-	132K	-
(Income) Loss On Equity Investments - (CF)	-	-	328K	201K	60.27K
Stock-Based Compensation (CF)	134K	1.76M	2.71M	2.34M	1.57M
Other Operating Activities, Total	93.75K	132K	-159K	-	163K
Change In Accounts Receivable	218K	-14.14K	-28.77K	-26.68K	-63.4K
Change In Inventories	-57.87K	-164K	-22.4K	24.17K	-905
Change In Accounts Payable	-200K	-42.6K	114K	904K	925K
Change in Unearned Revenues	4.27M	-714K	-3.57M	114K	289K
Change In Income Taxes	912	150	-392	-	-
Change In Deferred Taxes	433	36	-	810	-1.95K
Change in Other Net Operating Assets	-1.28M	89.3K	-103K	237K	-676K
Cash from Operations	1.37M	-4.78M	-6.03M	-6.6M	-4.76M
Capital Expenditure	-115K	-49.26K	-416K	-10.78K	-445K
Cash Acquisitions	-	-	-	-	-2.04M
Sale (Purchase) of Intangible assets	-	-39.67K	-38.94K	-1.94K	-
Investment in Marketable and Equity Securities, Total	-	-98.08K	-1.7M	-68.49K	-8.45K
Other Investing Activities, Total	-	-240	-	-	-
Cash from Investing	-115K	-187K	-2.15M	-81.22K	-2.49M
Short Term Debt Issued, Total	-	158K	-	800K	3.16M
Long-Term Debt Issued, Total	-	3M	-	-	-
Total Debt Issued	-	3.16M	-	800K	3.16M
Short Term Debt Repaid, Total	-229K	-770K	-250K	-	-
Long-Term Debt Repaid, Total	-	-40K	-	-	-1.5M
Total Debt Repaid	-229K	-810K	-250K	-	-1.5M
Issuance of Common Stock	-	11.48M	4.02M	290K	5.73M
Cash from Financing	-229K	13.82M	3.77M	1.09M	7.39M
Net Change in Cash	1.03M	8.86M	-4.41M	-5.59M	142K
Supplemental Items
Cash Interest Paid	84.04K	253K	52.6K	-	9.64K
Cash Income Tax Paid (Refund)	912	1.06K	3.31K	800	-
Levered Free Cash Flow	-2.23M	-1.07M	-1.16M	-2.51M	641K
Unlevered Free Cash Flow	-2.33M	-1.79M	-1.56M	-2.53M	500K
Change In Net Working Capital	1.41M	48.06K	717K	-1.47M	-3.4M
Net Debt Issued / Repaid	-229K	2.35M	-250K	800K	1.66M

Fiscal Period: December	2019	2020	2021	2022	2023
Profitability
Return on Assets	-82.32	-54.1	-30.45	-91.17	-33.85
Return on Total Capital	37.92	-211.33	-40.88	-119.44	-75.1
Return On Equity %	67.34	-822.59	-101.96	-343.99	18.95K
Return on Common Equity	67.34	-822.59	-101.96	-343.99	264.09
Margin Analysis
Gross Profit Margin %	90.56	92.38	96.96	65.1	35.96
SG&A Margin	205.03	584.71	216.7	1.29K	247.85
EBITDA Margin %	-113.74	-530.52	-124.73	-1.28K	-217.38
EBITA Margin %	-114.16	-531.5	-125.35	-1.29K	-224.04
EBIT Margin %	-114.47	-531.67	-125.39	-1.29K	-224.04
Income From Continuing Operations Margin %	-146.43	-804.73	-159.97	-1.32K	-266
Net Income Margin %	-146.43	-804.73	-159.97	-1.32K	-266
Net Avail. For Common Margin %	-146.43	-804.73	-159.97	-1.32K	-266
Normalized Net Income Margin	-87.54	-502.95	-102.3	-827.79	-160.44
Levered Free Cash Flow Margin	-150.84	-103.25	-27.89	-305.75	21.24
Unlevered Free Cash Flow Margin	-157.63	-172.79	-37.44	-307.63	16.55
Asset Turnover
Asset Turnover	1.15	0.16	0.39	0.11	0.24
Fixed Assets Turnover	12.91	5.1	3.03	0.34	0.69
Receivables Turnover (Average Receivables)	12.68	70.91	115.29	12.89	27.75
Inventory Turnover (Average Inventory)	1.93	0.43	0.46	1.04	7.33
Short Term Liquidity
Current Ratio	1.03	4.61	5.03	0.18	0.15
Quick Ratio	0.83	4.42	4.58	0.05	0.05
Operating Cash Flow to Current Liabilities	0.91	-2.09	-4.81	-1.94	-0.58
Days Sales Outstanding (Average Receivables)	28.78	5.16	3.17	28.33	13.15
Days Outstanding Inventory (Average Inventory)	189.33	849.2	799.11	350.71	49.82
Average Days Payable Outstanding	857.92	446.86	947.73	1.24K	346.96
Cash Conversion Cycle (Average Days)	-639.8	407.51	-145.45	-865.96	-283.99
Long Term Solvency
Total Debt/Equity	-12.32	13.49	29.05	-272.52	972.59
Total Debt / Total Capital	-14.05	11.89	22.51	157.96	90.68
LT Debt/Equity	-11.74	1.02	26.01	-170.82	758.95
Long-Term Debt / Total Capital	-13.39	0.9	20.16	99.01	70.76
Total Liabilities / Total Assets	306.83	47.54	30.15	123.82	95.73
EBIT / Interest Expense	-4.47	-1.94	-4.12	-178.76	-7.31
EBITDA / Interest Expense	-4.39	-1.93	-4.08	-177.46	-7.09
(EBITDA - Capex) / Interest Expense	-4.69	-1.95	-4.41	-177.64	-7.57
Total Debt / EBITDA	-0.27	-0.14	-0.41	-0.25	-1.32
Net Debt / EBITDA	0.47	1.7	0.69	-0.24	-1.29
Total Debt / (EBITDA - Capex)	-0.26	-0.14	-0.38	-0.25	-1.24
Net Debt / (EBITDA - Capex)	0.44	1.69	0.64	-0.24	-1.21
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %